| pubmed-article:18057933 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:18057933 | lifeskim:mentions | umls-concept:C0011109 | lld:lifeskim |
| pubmed-article:18057933 | lifeskim:mentions | umls-concept:C2350390 | lld:lifeskim |
| pubmed-article:18057933 | lifeskim:mentions | umls-concept:C0010181 | lld:lifeskim |
| pubmed-article:18057933 | lifeskim:mentions | umls-concept:C0205210 | lld:lifeskim |
| pubmed-article:18057933 | lifeskim:mentions | umls-concept:C1139717 | lld:lifeskim |
| pubmed-article:18057933 | pubmed:issue | 5 | lld:pubmed |
| pubmed-article:18057933 | pubmed:dateCreated | 2008-4-14 | lld:pubmed |
| pubmed-article:18057933 | pubmed:abstractText | The purpose of the study is to determine the impact of 13N-ammonia positron emission tomography (PET) myocardial perfusion imaging (MPI) on clinical decision making and its cost-effectiveness. | lld:pubmed |
| pubmed-article:18057933 | pubmed:commentsCorrections | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18057933 | pubmed:language | eng | lld:pubmed |
| pubmed-article:18057933 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18057933 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:18057933 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18057933 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18057933 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:18057933 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:18057933 | pubmed:month | May | lld:pubmed |
| pubmed-article:18057933 | pubmed:issn | 1619-7070 | lld:pubmed |
| pubmed-article:18057933 | pubmed:author | pubmed-author:AlkadhiHatemH | lld:pubmed |
| pubmed-article:18057933 | pubmed:author | pubmed-author:KaufmannPhili... | lld:pubmed |
| pubmed-article:18057933 | pubmed:author | pubmed-author:HusmannLarsL | lld:pubmed |
| pubmed-article:18057933 | pubmed:author | pubmed-author:SiegristPatri... | lld:pubmed |
| pubmed-article:18057933 | pubmed:author | pubmed-author:ScheffelHansH | lld:pubmed |
| pubmed-article:18057933 | pubmed:author | pubmed-author:StolzmannPaul... | lld:pubmed |
| pubmed-article:18057933 | pubmed:author | pubmed-author:GaemperliOliv... | lld:pubmed |
| pubmed-article:18057933 | pubmed:author | pubmed-author:ValentaInesI | lld:pubmed |
| pubmed-article:18057933 | pubmed:author | pubmed-author:KnabenhansMar... | lld:pubmed |
| pubmed-article:18057933 | pubmed:author | pubmed-author:Hoefflinghaus... | lld:pubmed |
| pubmed-article:18057933 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:18057933 | pubmed:volume | 35 | lld:pubmed |
| pubmed-article:18057933 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:18057933 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:18057933 | pubmed:pagination | 889-95 | lld:pubmed |
| pubmed-article:18057933 | pubmed:meshHeading | pubmed-meshheading:18057933... | lld:pubmed |
| pubmed-article:18057933 | pubmed:meshHeading | pubmed-meshheading:18057933... | lld:pubmed |
| pubmed-article:18057933 | pubmed:meshHeading | pubmed-meshheading:18057933... | lld:pubmed |
| pubmed-article:18057933 | pubmed:meshHeading | pubmed-meshheading:18057933... | lld:pubmed |
| pubmed-article:18057933 | pubmed:meshHeading | pubmed-meshheading:18057933... | lld:pubmed |
| pubmed-article:18057933 | pubmed:meshHeading | pubmed-meshheading:18057933... | lld:pubmed |
| pubmed-article:18057933 | pubmed:meshHeading | pubmed-meshheading:18057933... | lld:pubmed |
| pubmed-article:18057933 | pubmed:meshHeading | pubmed-meshheading:18057933... | lld:pubmed |
| pubmed-article:18057933 | pubmed:meshHeading | pubmed-meshheading:18057933... | lld:pubmed |
| pubmed-article:18057933 | pubmed:meshHeading | pubmed-meshheading:18057933... | lld:pubmed |
| pubmed-article:18057933 | pubmed:meshHeading | pubmed-meshheading:18057933... | lld:pubmed |
| pubmed-article:18057933 | pubmed:meshHeading | pubmed-meshheading:18057933... | lld:pubmed |
| pubmed-article:18057933 | pubmed:meshHeading | pubmed-meshheading:18057933... | lld:pubmed |
| pubmed-article:18057933 | pubmed:meshHeading | pubmed-meshheading:18057933... | lld:pubmed |
| pubmed-article:18057933 | pubmed:meshHeading | pubmed-meshheading:18057933... | lld:pubmed |
| pubmed-article:18057933 | pubmed:meshHeading | pubmed-meshheading:18057933... | lld:pubmed |
| pubmed-article:18057933 | pubmed:meshHeading | pubmed-meshheading:18057933... | lld:pubmed |
| pubmed-article:18057933 | pubmed:meshHeading | pubmed-meshheading:18057933... | lld:pubmed |
| pubmed-article:18057933 | pubmed:meshHeading | pubmed-meshheading:18057933... | lld:pubmed |
| pubmed-article:18057933 | pubmed:year | 2008 | lld:pubmed |
| pubmed-article:18057933 | pubmed:articleTitle | (13)N-ammonia myocardial perfusion imaging with a PET/CT scanner: impact on clinical decision making and cost-effectiveness. | lld:pubmed |
| pubmed-article:18057933 | pubmed:affiliation | Cardiovascular Center, University Hospital Zurich, Raemistrasse 100, CH-8091, Zurich, Switzerland. | lld:pubmed |
| pubmed-article:18057933 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:18057933 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:18057933 | lld:pubmed |
